期刊文献+

慢病毒介导的NOB1基因沉默对人结肠癌细胞增殖及凋亡的影响 被引量:5

Effect of lentivirus-mediated NOB1 gene silencing by RNA interference on proliferation and apoptosis of human colon cancer cells
原文传递
导出
摘要 目的探讨RNA干扰技术沉默人NOB1基因对人结肠癌RKO细胞增殖和凋亡的影响。方法设计靶向NOB1基因的小干扰RNA(siRNA),构建NOB1基因特异性的RNA干扰慢病毒载体,感染RKO细胞,并设置阴性对照组。实时定量PCR和Westemblot分别检测两组细胞NOB1mRNA及蛋白的表达情况;CellomicsArrayScanVTIHCS高内涵分析仪检测感染细胞的增殖和克隆形成能力;流式细胞术检测细胞周期及凋亡的变化:裸鼠成瘤实验检测0NOB1-siRNA对肿瘤的抑制作用。结果NOB1-shRNA慢病毒感染RKO细胞3d后.与阴性对照组比较.NOB1mRNA和蛋白的表达明显降低,克隆形成数减少,而细胞凋亡数增加(均P〈0.05)。裸鼠成瘤实验结果显示,NOB1.shRNA感染组裸鼠移植瘤体积为(405±102)mm3,小于阴性对照组的(870±165)mm3(P〈0.05)。结论通过RNA干扰方式沉默NOB1基因的表达.有望作为抑制结肠癌发展的有效手段。 Objective To investigate the effect of NOB1 gene on proliferation and apoptosis of human colon cancer cell line RKO by RNA interference. Methods Small interference RNA (siRNA) targeting NOB1 gene was cloned into lentivirus vector. Then the lentivirus particles expressing NOB1 short harpin RNA (shRNA) were infected into RKO cells. Real-time PCR and Western blot were performed to examine the expression of NOB1 in lentivirus infected cells. The Thermo Scientific Cellomics ArrayScan VTI HCS Reader was used to test the proliferation and colony-formation of RKO cells, and flow cytometry assay was performed to detect cell cycle and apoptosis. Xenograft tumor was established by injection of RKO cells into nude mice, then NOBI-shRNA was injected into the tumor and tumor volume was detected. Results Compared to negative controls, the expression levels of NOB1 mRNA and protein were both significantly down-regulated, the proliferation and colony-forming capacity of RKO cells were significantly inhibited, and cell apoptosis was increased after 3 days of NOB1-shRNA lentivirus infection (all P〈0.05). The tumor volume was significantly smaller in NOB1- shRNA group than that in Scr-shRNA group [(405±102) mm3 vs. (870±165) mm3, P〈0.05]. Conclusion Silencing NOB1 gene by RNA interference may provide an inhibitive effect on human colon cancer development.
出处 《中华胃肠外科杂志》 CAS 2012年第11期1182-1186,共5页 Chinese Journal of Gastrointestinal Surgery
基金 浙江省医药卫生科技计划类基金2010KYA178
关键词 结肠肿瘤 RNA干扰 增殖 凋亡 Colonic neoplasms RNA interference Proliferation Apoptosis
  • 相关文献

参考文献10

  • 1Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther, 2005,12(3) :217-227.
  • 2Angaji SA, Hedayati SS, Poor RH, et al. Application of RNA interference in treating human diseases. J Genet, 2010,89(4): 527-537.
  • 3Tone Y, Tanahashi N, Tanaka K, et al. Noblp, a new essential protein associates with the 26S proteasome of growing saccharomyces cerevisiae cells. Gene, 2000,243 (1-2) : 37-45.
  • 4Zhang Y, Ni J, Zhou G, et al. Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep, 2005,32(3) : 185-189.
  • 5Han Y, Hong L, Zhong C, et al. The expression of NOB1 in spiral ganglion ceils of guinea pig. Int J Pediatr Otorhinolaryngol, 2009,73 (2) : 315-319.
  • 6Hong L, Piao Y, Han Y, et al. Zinc ribbon domain-containing 1 (ZNRD1)mediates muhidrug resistance of leukemia ceils through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther, 2005,4(12) : 1936-1942.
  • 7Hong L, Qiao T, Han Y, et al. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem Cell Biol, 2006,84(2) : 199-206.
  • 8I-long L, Ning X, Shi Y, et al. Reversal of multidrug resistance of gastric cancer ceils by down-regulation of ZNRDI with ZNRD1 siRNA. Br J Biomed Sci, 2004,61(4):206-210.
  • 9Zhao Y, Hong L, Wang R, et al. Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. Dig Dis Sci, 2009,54(3) :586-592.
  • 10林杨,崔满华,许天敏,滕红,于伟.NOB1基因shRNA慢病毒载体的构建及其对卵巢癌SKOV3细胞增殖的影响[J].中国妇幼保健,2010,25(9):1257-1259. 被引量:4

二级参考文献8

  • 1Ferrell K, Wilkinson CR, Dubiel Wet al. Regulatory subunit interactions of the 26S proteasome, a complex problem [J]. Trends Biochem Sci, 2000, 25:83.
  • 2Lynch KW. Regulation of alternative splicing by signal transduction pathways [J]. Adv Exp Med Biol, 2007, 623:161.
  • 3Tone Y, Tanahashi N, Tanaka K et al. Nobl p, a new essential protein, associates with the 26S proteasome of growing saccharomyces cerevisiae cells [J]. Gene, 2000, 243:37.
  • 4Tone Y, Toh - E A. Noblp is required for biogenesis of the 26S proteasome and degraded upon its maturation in saccharomyces cerevisiae [J]. Gene Dev, 2002, 16:3142.
  • 5Gerbi SA, Borovjagin AV, Lange TS. The nucleolus: a site of ribonucleoprotein maturation[J]. Curr Opin Cell Biol, 2003, 15:318.
  • 6Fatica A, Oeftlnger M, Dlakic Met al. Nobl p is required for cleavage of the 3'end of 18S rRNA[J]. Mol Cell Biol, 2003, 23:1798.
  • 7Han Y, Hong L, Qiu Jet al. Preparation and characterization of a novel monoclonal antibody specific to human NOB1 Protein[J]. Hybridoma, 2008, 27 (3) : 187.
  • 8Zhang Y, Ni J, Zhou GJ, et al. Cloning, expression and characterization of the human NOB1 gene[J]. Molecular Biology Reports, 2005, 32:185.

共引文献3

同被引文献41

  • 1倪晓光,赵平.泛素-蛋白酶体途径与恶性肿瘤关系的研究进展[J].中华肿瘤防治杂志,2007,14(19):1512-1515. 被引量:20
  • 2Gayther S A. Inherited risk of ovarian cancer and the implications for screening[ J ]. Int J Gynecol Cancer, 2012,5 (22) : S12 - 5.
  • 3Zhang J, Zhang F, Li H, et al. Recent progress and future poten- tial for metal complexes as anticancer drugs targeting G-quadruplexDNA [ J]. Curr Med Chem, 2012,19 ( 18 ) :2957 - 75.
  • 4Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in themammalian cell cycle mutant ts85 [ J]. Cell, 1984, 37 ( 1 ) : 57 - 66.
  • 5Ciechanover A, DiGiuseppe J A, Bercovich B, et al. Degradation of nuclear oncoproteins by the ubiquitin system in vitro [ J ]. Proc Natl Acad Sci U S A,1991, 88(1) : 139 -43.
  • 6Agrawal A, Dang S, Gabrani R. Recent patents on anti-telomerase cancer therapy[ J]. Recent Pat Anticancer Drug Discov, 2012,7 (1):102-17.
  • 7Zhang C, Pei J, Kumar D, et al. Antisense oligonucleotides : tar- get validation and development of systemically delivered therapeu- tic nanoparticles[ J]. Methods Mol Biol, 2007,361:163 -85.
  • 8FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [ J ]. Int J Can, 2010, 127(12) : 2893 -2917.
  • 9BORNSCHEIN J, ROKKAS T, SELGRAD M, et al. Gastric cancer: clinical aspects, epidemiology and molecular background [J]. Helicobacter, 2011, 16(s1): 45-52.
  • 10CORREIA M, MACHADO J C, RISTIM)KI A. Basic aspects of gastric cancer[J]. Helicobacter, 2009, 14(Suppl 1 ) : 36 -40.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部